
Gold nanoparticle aggregates (red) are observed inside triple negative breast cancer cells after an enzyme-activated assembly and internalization process.
(photo credit: Richard Huang and Ye He)
The breakthrough advance could lead to a novel, drug-free therapeutic that can slow, possibly stop, the growth of cancer cells
A multi-institutional research team has designed nanoparticles that can communicate with and slow the development of cancer cells. The work — detailed in a newly published paper in Advanced Materials — has uncovered a novel framework for the potential development of drug-free cancer therapies.
Led by scientists at the Advanced Science Research Center at the Graduate Center, CUNY (CUNY ASRC), the research team was able to design nanoparticles that are activated to self-assemble when they encounter cancer cells and send messages to instruct the cells to slow their growth. Because the nanoparticles communicate only with the cancer cells, the surrounding healthy cells aren’t impacted.
“Cancer cells take up materials from their environment, and they also secrete factors that help them degrade surrounding tissue in order to spread and metastasize,” said Richard Huang, lead author of the paper, a Ph.D. student at the Graduate Center, CUNY (GC CUNY), and a researcher with the CUNY ASRC Nanoscience Initiative and the Center for Discovery and Innovation at CUNY’s City College of New York (CCNY). “We made particles that respond to both of these characteristics by aggregating into clusters that are actively taken up by cancer cells. Once inside, they appear to be able to reduce the cancer cells’ metabolic activity and consequently reduce their growth.
One reason the progression of cancer is difficult to control is that the cells secrete an abnormally large amount of the matrix metalloproteinase-9 (MMP-9) enzyme, which breaks down the collagen that holds together healthy tissue. The research team was able to use this feature against the cancer cells. This is achieved by designing nanoparticles that when triggered by MMP-9, begin assembling to large aggregates in the cells’ vicinity. The cells engulf these aggregates, and their size causes physical distress to the cancer cells and reduces their ability to proliferate and survive.
One highlight of the study is that the researchers were able to use confocal reflection microscopy to visualize the nanoparticle aggregates inside the cancer cells in real-time. “This label-free, live imaging technique allowed us to have a closer look at when and where the aggregates were formed, and how the cancer cells respond to the particles at the sub-cellular level,” said Ye He, director of the Live Imaging and Bioenergetics Facility in the CUNY ASRC Neuroscience Initiative.
“Through this research, we wanted to determine whether it’s possible to make use of relatively simple peptide design to create nanoparticles that could produce robust self-assembly in biological media and have an impact on cancer cells,” said Rein Ulijn, director of the CUNY ASRC Nanoscience Initiative and the study’s principal investigator. “While this is early-stage research, the findings provide exciting possibilities for a drug-free therapeutic treatment that could be extremely useful for cancer patients who have developed drug resistance and for extending the lives of people with metastatic cancer.”
Further studies are needed to fully access the therapeutic potential of the team’s discovery.
Original Article: Scientists Design Nanoparticles That Communicate With Cancer Cells
More from: City University of New York | University of Strathclyde | Weizmann Institute of Science
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Self-assembling nanoparticles
- Lipid-based Nanoparticles in the Systemic Delivery of siRNA
Nanoplatforms have higher biocompatibility and lower toxicity in comparison with inorganic nanoparticles and viral vectors. Function-engineerable nanoparticles in combination with the advantageous ...
- Controlling the degree of twist in nanostructured particles for the first time
Micron-sized "bow ties," self-assembled from nanoparticles, form a variety of different curling shapes that can be precisely controlled, a research team led by the University of Michigan has shown.
- How Does Nanoparticle Size Impact Tumor Treatment?
Nanoparticle technology has become a revolutionary breakthrough for cancer therapeutics, with nanoparticles and nanoscale devices being between 1 and 100 nm in size. Image Credit: ...
- Durable selenium nanoparticle fabrics with antiviral and antibacterial properties
This element is a photoelectrically active semiconductor that has been applied in solar cell assembly, xerography, and glass production. Se nanoparticles (SeNPs) exhibit coloring capabilities ...
- Journal of biomedical nanotechnology
Oleic Acid Double Coated Fe₃O₄ Nanoparticles as Anti-Melanoma Compounds with a Complex Mechanism of Activity-In Vitro and In Ovo Assessment. Detection of Nucleic Acids and Prevention of ...
Go deeper with Google Headlines on:
Self-assembling nanoparticles
[google_news title=”” keyword=”self-assembling nanoparticles” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Drug-free cancer treatment
- AI develops cancer treatment in 30 days, predicts survival rate
they discovered a more potent hit molecule — but any potential drug would need to go through clinical trials before widespread use. Artificial intelligence has developed a treatment for cancer ...
- Artificial intelligence develops cancer treatment in just 30 days - and predicts how long patients have to live by reading doctors' notes
using an AI drug discovery platform called Pharma. HCC is a form of liver cancer, but the AI discovered a previously unknown treatment pathway and designed a 'novel hit molecule' that could bind ...
- Sam Neill, Receiving Treatment For Stage Three Blood Cancer, Says He’s “Just Pleased To Be Alive”
Sam Neill first noticed he had swollen glands while promoting Jurassic World Dominion last March. After consulting a physician, the actor was diagnosed with angioimmunoblastic T-cell lymphoma, a ...
- Sam Neill reveals treatment for blood cancer: ‘Possibly dying’
Sam Neill reveals his secret battle with stage 3 blood cancer in his upcoming memoir “Did I Ever Tell You This?” The 75-year-old “Jurassic Park” star recalled experiencing swollen glands a year ago ...
- Sam Neill Reveals Treatment for Blood Cancer: ‘I’m Not Afraid to Die’
The "Jurassic Park" actor was diagnosed with angioimmunoblastic T-cell lymphoma during the "Jurassic World: Dominion" press tour.
Go deeper with Google Headlines on:
Drug-free cancer treatment
[google_news title=”” keyword=”drug-free cancer treatment” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]